Koyama and colleagues that studied the TME in a mouse model of NSCLC mutated for KRAS and LKB1 have proposed a mechanistic explanation for the resistance to immunotherapy in these tumors. The gene discussed is STK11; the disease is non-small cell lung carcinoma.